Sephience 250 mg

Sephience 250 mg is a medicine authorised by Swissmedic under authorisation number 69810. The authorisation holder is PTC Therapeutics Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 August 2025 and the authorisation is limited until 04 August 2030. ATC code A16AX places the medicine in the group Other alimentary tract and metabolism products.

  • Dispensing category B
  • Authorisation number 69810
  • ATC A16AX
  • Synthetic medicines
Authorisation data
Authorisation number69810
NameSephience 250 mg
Full nameSephience 250 mg, Pulver zum Einnehmen
Authorisation holderPTC Therapeutics Switzerland GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA16AX
First authorisation05 August 2025
Authorisation validity04 August 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Sephience 250 mg, Pulver zum EinnehmenB05 August 2025
2Sephience 1000 mg, Pulver zum EinnehmenB05 August 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130BeutelA16AX07.99.0.B
230BeutelA16AX07.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Frequently asked questions

Is Sephience 250 mg authorised in Switzerland?

Yes. Sephience 250 mg is authorised by Swissmedic under authorisation number 69810, data as of 01 September 2026. The authorisation is limited until 04 August 2030.

Which dispensing category does Sephience 250 mg have?

Sephience 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Sephience 250 mg?

The authorisation holder is PTC Therapeutics Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com